Dimitrios Tzilves

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Helicobacter pylori and Porphyromonas gingivalis Infections as Potential Risk Predictors for Gastric Cancer and Two Types of Esophageal Cancer.

Helicobacter pylori and Porphyromonas gingivalis Infections as Potential Risk Predictors for Gastric Cancer and Two Types of Esophageal Cancer.

Journal: Journal of gastroenterology and hepatology

Published: May 16, 2026

Impact of Helicobacter pylori- and Porphyromonas gingivalis-associated metabolic syndrome on local and systemic disorders.

Impact of Helicobacter pylori- and Porphyromonas gingivalis-associated metabolic syndrome on local and systemic disorders.

Journal: Neuro endocrinology letters

Published: April 08, 2026

Endoscopist detection of Helicobacter pylori-related adenomas may be associated with an increased risk of neoplasia during follow-up colonoscopies, by initial combined conventional histology and immunohistochemical testing in colorectal cancer screening.

Endoscopist detection of Helicobacter pylori-related adenomas may be associated with an increased risk of neoplasia during follow-up colonoscopies, by initial combined conventional histology and immunohistochemical testing in colorectal cancer screening.

Journal: Gastrointestinal endoscopy

Published: October 03, 2025

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease.

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: September 03, 2024

Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH.

Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH.

Journal: Alimentary pharmacology & therapeutics

Published: July 30, 2024

Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease.

Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: July 04, 2024

Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.

Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.

Journal: Journal of neurogastroenterology and motility

Published: July 07, 2023

Viewing the Current Puzzling Issue of COVID-19 Vaccination Safety in Older Adults.

Viewing the Current Puzzling Issue of COVID-19 Vaccination Safety in Older Adults.

Journal: Journal of the American Medical Directors Association

Published: May 18, 2023

Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.

Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.

Journal: Alimentary pharmacology & therapeutics

Published: April 24, 2023

Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.

Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.

Journal: Journal of viral hepatitis

Published: March 22, 2023

Endoscopic ultrasonography in pancreatic diseases: advances in tissue acquisition.

Endoscopic ultrasonography in pancreatic diseases: advances in tissue acquisition.

Journal: Endoscopy international open

Published: January 19, 2019

Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence.

Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence.

Journal: Helicobacter

Published: September 14, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026